Melanoma,Skin Cancer Combined Efficacy of RP1 and Nivolumab in Anti-PD-1-Failed Melanoma Oct 05, 2023
Melanoma,Skin Cancer 1L Treatment of Inoperable BRAF V600-Mutant Melanoma With Enco, Bini, and Pembro Oct 03, 2023
Melanoma,Skin Cancer Path Response to Neoadjuvant Nivo and Rela in High-Risk Stage II Melanoma Sep 07, 2023
Melanoma Combination Therapy of Cobimetinib and Atezolizumab in BRAFV600 Wild-Type Melanoma Patients Aug 29, 2023
Melanoma,Skin Cancer Anti-LAG-3 Plus Anti-PD-1 Vs. Pembrolizumab in Pts With Completely Resected High-Risk Melanoma Aug 14, 2023
BCC (Basal Cell Carcinoma),SCC (Squamous Cell Carcinoma),Skin Cancer Intralesional T-VEC Induces Clinical Responses and Activates Immune Response in CBCL Lesions Aug 14, 2023
Melanoma,Skin Cancer Phase 3 Trial: Fianlimab + Cemiplimab vs. Pembrolizumab in High-Risk Melanoma Jul 31, 2023
